Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

61.48
Delayed Data
As of Jan 17
 -0.86 / -1.38%
Today’s Change
47.97
Today|||52-Week Range
65.46
+4.43%
Year-to-Date

Today’s Trading

Previous close62.34
Today’s open61.92
Day’s range61.20 - 62.07
Volume10,592,686
Average volume (3 months)10,986,848
Market cap$171.9B
Dividend yield3.06%
Data as of 4:00pm ET, 01/17/2017

Growth & Valuation

Earnings growth (last year)-61.67%
Earnings growth (this year)+5.20%
Earnings growth (next 5 years)+6.50%
Revenue growth (last year)-7.92%
P/E ratio31.4
Price/Sales3.87
Price/Book3.88

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-0.41-0.57%
PFEPfizer-0.46-1.41%
SNYSanofi-0.51-1.23%
ABBVAbbVie-0.13-0.21%
Data as of 4:02pm ET, 01/17/2017

Financials

Next reporting dateFebruary 2, 2017
EPS forecast (this quarter)$0.88
Annual revenue (last year)$38.8B
Annual profit (last year)$4.4B
Net profit margin11.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts


Search for Jobs